1Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injuryJiahua Xie，Farooqahmed S.Kittur，P.Andy Li，Chiu-Yueh HungReviews1397-1403
2Microglia activation, classification and microglia-mediated neuroinflammatory modulators in subarachnoid hemorrhageJunfan Chen，Zhiyuan Vera Zheng，Gang Lu，Wai Yee Chan，Yisen Zhang，George Kwok Chu WongReviews1404-1411
3MicroRNA biomarkers in frontotemporal dementia and to distinguish from Alzheimer 's disease and amyotrophic lateral sclerosisBridget Martinez，Philip V.PeplowReviews1412-1422
4Protein synthesis modulation as a therapeutic approach for amyotrophic lateral sclerosis and frontotemporal dementiaSantiago E.Charif，M.Florencia Vassallu，Lara Salva?al，Lionel M.IgazReviews1423-1430
5A novel viewpoint in glaucoma therapeutics: enriched environmentMaría F.González Fleitas，Damián Dorfman，Ruth E.RosensteinReviews1431-1439
7The role of L-arginine metabolism in neurocritical care patientsMarius Marc-Daniel Mader，Patrick CzorlichReviews1446-1453
8Homer signaling pathways as effective therapeutic targets for ischemic and traumatic brain injuries and retinal lesionsXiu-Quan Wu，Ning Su，Zhou Fei，Fei FeiReviews1454-1461
9Is activation of GDNF/RET signaling the answer for successful treatment of Parkinson's disease? A discussion of data from the culture dish to the clinicJames A.Conway，Edgar R.KramerReviews1462-1467
11Neuronal and endothelial transglutaminase-2 expression in experimental autoimmune encephalomyelitis and multiple sclerosisDamien D.Pearse，Mousumi GhoshPerspectives1471-1472
12Lycium barbarum polysaccharides and ferroptosis: jumping into the era of novel regulated cell deathAmy Cheuk Yin Lo，Ming YangPerspectives1473-1474
13Morpholino studies shed light on the signaling pathways regulating axon regeneration in lampreysDaniel Sobrido-Cameán，Antón Barreiro-IglesiasPerspectives1475-1477
14Quo vadis? Bioengineered polysaccharide-based hydrogel scaffolds for damaged central nervous system recovery and regenerationIsadora C.Carvalho，Herman S.MansurPerspectives1478-1480
15CXCR4 signaling in central nervous system regeneration: friend or foe?Daniel Terheyden-Keighley，Alexander M.Hilla，Dietmar FischerPerspectives1481-1483
16Therapeutic potential of prophylactic exercise for intracerebral hemorrhageKeita Kinoshita，Kelly K.Chung，Hiroshi Katsuki，Ken AraiPerspectives1484-1485
17The role of lysosomes in alpha-synucleinopathies: a focus on glial cellsDenise Balta，Friederike ZunkePerspectives1486-1488
18Targeting the motor cortex to restore walking after incomplete spinal cord injuryMarina MartinezPerspectives1489-1490
19Impact of alpha-synuclein pathology on adult neurogenesis: evidence for multilayered mechanismsJana Bonsberger，Franziska Richter，Milos StanojlovicPerspectives1491-1492
20Neurotrophin receptors, gamma-secretase inhibitors, and neurodegeneration of basal forebrain cholinergic neuronsMar?al VilarPerspectives1493-1494
